132 related articles for article (PubMed ID: 20056645)
1. Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome.
Couch FJ; Wang X; Bamlet WR; de Andrade M; Petersen GM; McWilliams RR
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):251-7. PubMed ID: 20056645
[TBL] [Abstract][Full Text] [Related]
2. Association of breast cancer susceptibility variants with risk of pancreatic cancer.
Couch FJ; Wang X; McWilliams RR; Bamlet WR; de Andrade M; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3044-8. PubMed ID: 19843670
[TBL] [Abstract][Full Text] [Related]
3. Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk.
Jang JH; Cotterchio M; Borgida A; Liu G; Gallinger S; Cleary SP
Mol Carcinog; 2013 Nov; 52 Suppl 1(0 1):E103-9. PubMed ID: 23908141
[TBL] [Abstract][Full Text] [Related]
4. Variation in genes required for normal mitosis and risk of breast cancer.
Olson JE; Wang X; Goode EL; Pankratz VS; Fredericksen ZS; Vierkant RA; Pharoah PD; Cerhan JR; Couch FJ
Breast Cancer Res Treat; 2010 Jan; 119(2):423-30. PubMed ID: 19377877
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.
McWilliams RR; Bamlet WR; de Andrade M; Rider DN; Couch FJ; Cunningham JM; Matsumoto ME; Rabe KG; Hammer TJ; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2549-52. PubMed ID: 19690177
[TBL] [Abstract][Full Text] [Related]
6. Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer.
Feng Y; Liu H; Duan B; Liu Z; Abbruzzese J; Walsh KM; Zhang X; Wei Q
Carcinogenesis; 2019 Jun; 40(4):521-528. PubMed ID: 30794721
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L.
McWilliams RR; Bamlet WR; de Andrade M; Rider DN; Cunningham JM; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1295-302. PubMed ID: 19318433
[TBL] [Abstract][Full Text] [Related]
8. CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome.
Shamai S; Nabiochtchikov I; Kraus S; Zigdon S; Kazanov D; Itzhak-Klutch M; Eizner C; Arber N; Geva R
PLoS One; 2015; 10(9):e0134469. PubMed ID: 26394139
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D metabolic pathway genes and pancreatic cancer risk.
Arem H; Yu K; Xiong X; Moy K; Freedman ND; Mayne ST; Albanes D; Arslan AA; Austin M; Bamlet WR; Beane-Freeman L; Bracci P; Canzian F; Cotterchio M; Duell EJ; Gallinger S; Giles GG; Goggins M; Goodman PJ; Hartge P; Hassan M; Helzlsouer K; Henderson B; Holly EA; Hoover R; Jacobs EJ; Kamineni A; Klein A; Klein E; Kolonel LN; Li D; Malats N; Männistö S; McCullough ML; Olson SH; Orlow I; Peters U; Petersen GM; Porta M; Severi G; Shu XO; Visvanathan K; White E; Yu H; Zeleniuch-Jacquotte A; Zheng W; Tobias GS; Maeder D; Brotzman M; Risch H; Sampson JN; Stolzenberg-Solomon RZ
PLoS One; 2015; 10(3):e0117574. PubMed ID: 25799011
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer.
Stevens KN; Wang X; Fredericksen Z; Pankratz VS; Cerhan J; Vachon CM; Olson JE; Couch FJ
Breast Cancer Res Treat; 2011 Sep; 129(2):617-22. PubMed ID: 21607584
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
Liu X; Qian D; Liu H; Abbruzzese JL; Luo S; Walsh KM; Wei Q
Mol Carcinog; 2020 Aug; 59(8):930-939. PubMed ID: 32367578
[TBL] [Abstract][Full Text] [Related]
12. Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer.
Reid-Lombardo KM; Fridley BL; Bamlet WR; Cunningham JM; Sarr MG; Petersen GM
Ann Surg; 2013 Jun; 257(6):1096-102. PubMed ID: 23360921
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer susceptibility loci and their role in survival.
Rizzato C; Campa D; Giese N; Werner J; Rachakonda PS; Kumar R; Schanné M; Greenhalf W; Costello E; Khaw KT; Key TJ; Siddiq A; Lorenzo-Bermejo J; Burwinkel B; Neoptolemos JP; Büchler MW; Hoheisel JD; Bauer A; Canzian F
PLoS One; 2011; 6(11):e27921. PubMed ID: 22125638
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study of survival in patients with pancreatic adenocarcinoma.
Wu C; Kraft P; Stolzenberg-Solomon R; Steplowski E; Brotzman M; Xu M; Mudgal P; Amundadottir L; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; Kooperberg C; Petersen GM; Zheng W; Albanes D; Boutron-Ruault MC; Buring JE; Canzian F; Cao G; Duell EJ; Elena JW; Gaziano JM; Giovannucci EL; Hallmans G; Hutchinson A; Hunter DJ; Jenab M; Jiang G; Khaw KT; LaCroix A; Li Z; Mendelsohn JB; Panico S; Patel AV; Qian ZR; Riboli E; Sesso H; Shen H; Shu XO; Tjonneland A; Tobias GS; Trichopoulos D; Virtamo J; Visvanathan K; Wactawski-Wende J; Wang C; Yu K; Zeleniuch-Jacquotte A; Chanock S; Hoover R; Hartge P; Fuchs CS; Lin D; Wolpin BM
Gut; 2014 Jan; 63(1):152-60. PubMed ID: 23180869
[TBL] [Abstract][Full Text] [Related]
15. Association of genetic variation in mitotic kinases with breast cancer risk.
Wang X; Fredericksen ZS; Vierkant RA; Kosel ML; Pankratz VS; Cerhan JR; Justenhoven C; Brauch H; ; Olson JE; Couch FJ
Breast Cancer Res Treat; 2010 Jan; 119(2):453-62. PubMed ID: 19404734
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms.
Babic A; Bao Y; Qian ZR; Yuan C; Giovannucci EL; Aschard H; Kraft P; Amundadottir LT; Stolzenberg-Solomon R; Morales-Oyarvide V; Ng K; Stampfer MJ; Ogino S; Buring JE; Sesso HD; Gaziano JM; Rifai N; Pollak MN; Anderson ML; Cochrane BB; Luo J; Manson JE; Fuchs CS; Wolpin BM
Cancer Res; 2016 Dec; 76(24):7160-7167. PubMed ID: 27780823
[TBL] [Abstract][Full Text] [Related]
17. Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival.
Li D; Tanaka M; Brunicardi FC; Fisher WE; Gibbs RA; Gingras MC
Cancer; 2011 Jul; 117(13):2863-72. PubMed ID: 21692047
[TBL] [Abstract][Full Text] [Related]
18. A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival.
Willis JA; Olson SH; Orlow I; Mukherjee S; McWilliams RR; Kurtz RC; Klein RJ
Clin Cancer Res; 2012 Jul; 18(14):3942-51. PubMed ID: 22665904
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals.
Gentiluomo M; Peduzzi G; Lu Y; Campa D; Canzian F
Mutagenesis; 2019 Dec; 34(5-6):395-401. PubMed ID: 31748817
[TBL] [Abstract][Full Text] [Related]
20. Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.
Childs EJ; Chaffee KG; Gallinger S; Syngal S; Schwartz AG; Cote ML; Bondy ML; Hruban RH; Chanock SJ; Hoover RN; Fuchs CS; Rider DN; Amundadottir LT; Stolzenberg-Solomon R; Wolpin BM; Risch HA; Goggins MG; Petersen GM; Klein AP
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1185-91. PubMed ID: 27197284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
